| Dr Arthur Philip Fine, MD | |
|
812 Gorman Ave, Elkins, WV 26241-3181 | |
| (304) 636-3300 | |
| Not Available |
| Full Name | Dr Arthur Philip Fine |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 43 Years |
| Location | 812 Gorman Ave, Elkins, West Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134192867 | NPI | - | NPPES |
| 001145076/002 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | MD029758E (Pennsylvania) | Secondary |
| 208600000X | Surgery | 26616 (West Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Davis Medical Center | Elkins, WV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Davis Memorial Hospital | 3072418540 | 69 |
News Archive
To coincide with World Health Day on Thursday, the Infectious Diseases Society of America (IDSA) released a policy paper with nine recommendations for how to control the "ever-growing threat of antimicrobial resistance," CIDRAP News reports.
What started off as basic research 25 years ago has now lead to a successfully approved drug: The entry blocker bulevirtide (brand name Hepcludex, formerly known as Myrcludex B), jointly developed by researchers from Heidelberg University Hospital (UKHD) and the Medical Faculty of Heidelberg, the DZIF and other partners, has now been approved by the European Commission.
Arcadia Resources, Inc. (NYSE Amex: KAD), a leading provider of innovative consumer health care services under the Arcadia HealthCare(SM) brand, today announced President and CEO Marvin R. Richardson and CFO Matthew Middendorf will attend the Barrington Research Healthcare Conference on Tuesday, August 25.
Researchers at Lund University have succeeded in preventing very early symptoms of Huntington's disease, depression and anxiety, by deactivating the mutated huntingtin protein in the brains of mice.
In a study appearing in the journal PLoS ONE, Massachusetts General Hospital scientists describe finding mathematical patterns underlying the way individuals unconsciously distribute their preferences regarding approaching or avoiding objects in their environment.
› Verified 5 days ago
| Entity Name | Davis Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619964806 PECOS PAC ID: 3072418540 Enrollment ID: O20040107000438 |
News Archive
To coincide with World Health Day on Thursday, the Infectious Diseases Society of America (IDSA) released a policy paper with nine recommendations for how to control the "ever-growing threat of antimicrobial resistance," CIDRAP News reports.
What started off as basic research 25 years ago has now lead to a successfully approved drug: The entry blocker bulevirtide (brand name Hepcludex, formerly known as Myrcludex B), jointly developed by researchers from Heidelberg University Hospital (UKHD) and the Medical Faculty of Heidelberg, the DZIF and other partners, has now been approved by the European Commission.
Arcadia Resources, Inc. (NYSE Amex: KAD), a leading provider of innovative consumer health care services under the Arcadia HealthCare(SM) brand, today announced President and CEO Marvin R. Richardson and CFO Matthew Middendorf will attend the Barrington Research Healthcare Conference on Tuesday, August 25.
Researchers at Lund University have succeeded in preventing very early symptoms of Huntington's disease, depression and anxiety, by deactivating the mutated huntingtin protein in the brains of mice.
In a study appearing in the journal PLoS ONE, Massachusetts General Hospital scientists describe finding mathematical patterns underlying the way individuals unconsciously distribute their preferences regarding approaching or avoiding objects in their environment.
› Verified 5 days ago
| Entity Name | Point Pleasant Physician Billing Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396798898 PECOS PAC ID: 3375538184 Enrollment ID: O20040419001780 |
News Archive
To coincide with World Health Day on Thursday, the Infectious Diseases Society of America (IDSA) released a policy paper with nine recommendations for how to control the "ever-growing threat of antimicrobial resistance," CIDRAP News reports.
What started off as basic research 25 years ago has now lead to a successfully approved drug: The entry blocker bulevirtide (brand name Hepcludex, formerly known as Myrcludex B), jointly developed by researchers from Heidelberg University Hospital (UKHD) and the Medical Faculty of Heidelberg, the DZIF and other partners, has now been approved by the European Commission.
Arcadia Resources, Inc. (NYSE Amex: KAD), a leading provider of innovative consumer health care services under the Arcadia HealthCare(SM) brand, today announced President and CEO Marvin R. Richardson and CFO Matthew Middendorf will attend the Barrington Research Healthcare Conference on Tuesday, August 25.
Researchers at Lund University have succeeded in preventing very early symptoms of Huntington's disease, depression and anxiety, by deactivating the mutated huntingtin protein in the brains of mice.
In a study appearing in the journal PLoS ONE, Massachusetts General Hospital scientists describe finding mathematical patterns underlying the way individuals unconsciously distribute their preferences regarding approaching or avoiding objects in their environment.
› Verified 5 days ago
| Entity Name | Usa Vein Clinics Of Morgantown Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154961852 PECOS PAC ID: 6406287275 Enrollment ID: O20200511002765 |
News Archive
To coincide with World Health Day on Thursday, the Infectious Diseases Society of America (IDSA) released a policy paper with nine recommendations for how to control the "ever-growing threat of antimicrobial resistance," CIDRAP News reports.
What started off as basic research 25 years ago has now lead to a successfully approved drug: The entry blocker bulevirtide (brand name Hepcludex, formerly known as Myrcludex B), jointly developed by researchers from Heidelberg University Hospital (UKHD) and the Medical Faculty of Heidelberg, the DZIF and other partners, has now been approved by the European Commission.
Arcadia Resources, Inc. (NYSE Amex: KAD), a leading provider of innovative consumer health care services under the Arcadia HealthCare(SM) brand, today announced President and CEO Marvin R. Richardson and CFO Matthew Middendorf will attend the Barrington Research Healthcare Conference on Tuesday, August 25.
Researchers at Lund University have succeeded in preventing very early symptoms of Huntington's disease, depression and anxiety, by deactivating the mutated huntingtin protein in the brains of mice.
In a study appearing in the journal PLoS ONE, Massachusetts General Hospital scientists describe finding mathematical patterns underlying the way individuals unconsciously distribute their preferences regarding approaching or avoiding objects in their environment.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Arthur Philip Fine, MD 812 Gorman Ave, Elkins, WV 26241-3181 Ph: (304) 636-3300 | Dr Arthur Philip Fine, MD 812 Gorman Ave, Elkins, WV 26241-3181 Ph: (304) 636-3300 |
News Archive
To coincide with World Health Day on Thursday, the Infectious Diseases Society of America (IDSA) released a policy paper with nine recommendations for how to control the "ever-growing threat of antimicrobial resistance," CIDRAP News reports.
What started off as basic research 25 years ago has now lead to a successfully approved drug: The entry blocker bulevirtide (brand name Hepcludex, formerly known as Myrcludex B), jointly developed by researchers from Heidelberg University Hospital (UKHD) and the Medical Faculty of Heidelberg, the DZIF and other partners, has now been approved by the European Commission.
Arcadia Resources, Inc. (NYSE Amex: KAD), a leading provider of innovative consumer health care services under the Arcadia HealthCare(SM) brand, today announced President and CEO Marvin R. Richardson and CFO Matthew Middendorf will attend the Barrington Research Healthcare Conference on Tuesday, August 25.
Researchers at Lund University have succeeded in preventing very early symptoms of Huntington's disease, depression and anxiety, by deactivating the mutated huntingtin protein in the brains of mice.
In a study appearing in the journal PLoS ONE, Massachusetts General Hospital scientists describe finding mathematical patterns underlying the way individuals unconsciously distribute their preferences regarding approaching or avoiding objects in their environment.
› Verified 5 days ago
Dr. Christine Evankovich-edwards, M. D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 812 Gorman Ave, Elkins, WV 26241 Phone: 304-637-9302 Fax: 304-637-9306 | |
Dr. Nityananda Santra, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 911 Gorman Avenue, Suite 203, Elkins, WV 26241 Phone: 304-636-5229 Fax: 304-636-1015 | |
Buchanan Merryman Dugan, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 911 Gorman Ave, Ste 103, Elkins, WV 26241 Phone: 304-637-9302 Fax: 304-637-9306 | |
Robert A Rose, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 911 Gorman Ave, Suite 203, Elkins, WV 26241 Phone: 304-636-2817 | |
Joseph A Noronha, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 26 Cherry St, Elkins, WV 26241 Phone: 304-636-3488 Fax: 304-636-8811 |